(2S)-4-[6,7-dimethyl-4-[6-(trifluoromethyl)-3-pyridinyl]pteridin-2-yl]-2-(6-methylpyridazin-4-yl)morpholine
C23H21F3N8O — CID 157045279
Data last refreshed: (MolForge compound catalog, from PubChem)
About (2S)-4-[6,7-dimethyl-4-[6-(trifluoromethyl)-3-pyridinyl]pteridin-2-yl]-2-(6-methylpyridazin-4-yl)morpholine
(2S)-4-[6,7-dimethyl-4-[6-(trifluoromethyl)-3-pyridinyl]pteridin-2-yl]-2-(6-methylpyridazin-4-yl)morpholine (PubChem CID 157045279) has the molecular formula C23H21F3N8O and a molecular weight of 482.47 g/mol. Its IUPAC name is (2S)-4-[6,7-dimethyl-4-[6-(trifluoromethyl)-3-pyridinyl]pteridin-2-yl]-2-(6-methylpyridazin-4-yl)morpholine.
Molecular Properties
| Compound Name | (2S)-4-[6,7-dimethyl-4-[6-(trifluoromethyl)-3-pyridinyl]pteridin-2-yl]-2-(6-methylpyridazin-4-yl)morpholine |
|---|---|
| PubChem CID | 157045279 |
| Molecular Formula | C23H21F3N8O |
| Molecular Weight | 482.47 g/mol |
| Exact Mass | 482.18 |
| IUPAC Name | (2S)-4-[6,7-dimethyl-4-[6-(trifluoromethyl)-3-pyridinyl]pteridin-2-yl]-2-(6-methylpyridazin-4-yl)morpholine |
| SMILES | Cc1cc([C@H]2CN(c3nc(-c4ccc(C(F)(F)F)nc4)c4nc(C)c(C)nc4n3)CCO2)cnn1 |
| InChI | InChI=1S/C23H21F3N8O/c1-12-8-16(10-28-33-12)17-11-34(6-7-35-17)22-31-19(15-4-5-18(27-9-15)23(24,25)26)20-21(32-22)30-14(3)13(2)29-20/h4-5,8-10,17H,6-7,11H2,1-3H3/t17-/m1/s1 |
| InChIKey | KMOBIOKSYDAVSJ-QGZVFWFLSA-N |
| XLogP | 3.79 |
| TPSA | 102.70 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 35 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 482.47 |
| LogP ≤ 5 | 3.79 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 9 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 157045279 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.